Metropolitan Life Insurance Company (MetLife)’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,495
| Closed | -$15.3K | – | 1824 |
|
|
2024
Q1 | $15.3K | Buy |
1,495
+67
| +5% | +$685 | ﹤0.01% | 1979 |
|
|
2023
Q4 | $7.83K | Hold |
1,428
| – | – | ﹤0.01% | 2248 |
|
|
2023
Q3 | $5.4K | Hold |
1,428
| – | – | ﹤0.01% | 2387 |
|
|
2023
Q2 | $9.57K | Buy |
+1,428
| New | +$9.57K | ﹤0.01% | 2320 |
|
|
2021
Q4 | – | Sell |
-6,383
| Closed | -$63.7K | – | 2826 |
|
|
2021
Q3 | $63.7K | Buy |
+6,383
| New | +$63.7K | ﹤0.01% | 2727 |
|
|
2021
Q2 | – | Sell |
-4,038
| Closed | -$176K | – | 2861 |
|
|
2021
Q1 | $176K | Buy |
+4,038
| New | +$176K | ﹤0.01% | 2107 |
|